Modern Endoscopic Skull Base Neurosurgery
Overview
Affiliations
Introduction: Since the early use of the endoscopic view for treating simple intrasellar pituitary adenomas, the skull base surgery has experienced an unprecedented revolution elevating the treatment of skull base lesions to the next level in proficiency and excellence of care.
Methods: We have reviewed the preclinical and clinical evidence supporting the use of the endoscope in the treatment of skull base lesions. In this article, we aim to discuss and provide a wide view of the current indications and future perspectives of the endoscopic endonasal approaches (EEA) and of the endoscopic transcranial approaches.
Results: As in the development of any other technique, EEA have gone through a transformation process from theoretical anatomic models to a pragmatic clinical use. Along the way, EEA have required several modifications, as well as pushbacks in the application of this technique in some indications. This process has resulted in the provision of an additional tool to the current surgical armamentarium that allows the skull base surgeon to face most challenging lesions along the skull base.
Conclusions: The judicious combination of transcranial and endoscopic-transnasal approaches warrants highest chances of achieving satisfactory tumors resection with a reduced risk of complications.
Mansur G, Furtado L, Filho J, Faleiro R, Siqueira J, Raso J Neurosurg Rev. 2025; 48(1):260.
PMID: 39982514 DOI: 10.1007/s10143-025-03421-4.
Determinants of quality of life following resection of skull base tumors: a systematic review.
Sperl V, Rhomberg T, Kretschmer T Front Oncol. 2025; 14:1473261.
PMID: 39759154 PMC: 11696366. DOI: 10.3389/fonc.2024.1473261.
Kondo A Juntendo Iji Zasshi. 2024; 69(2):92-96.
PMID: 38854454 PMC: 11153056. DOI: 10.14789/jmj.JMJ23-0002-R.
Zhang Z, Li S, Wang Y, Wang Z, Wang X, Wang B Acta Neurochir (Wien). 2024; 166(1):127.
PMID: 38460009 DOI: 10.1007/s00701-024-06027-9.
Editorial: Recent advances in the mechanism and treatment of pituitary tumors.
Shi W, Liu Q, Jia F, Wang X Front Neurol. 2024; 14:1324189.
PMID: 38292035 PMC: 10825668. DOI: 10.3389/fneur.2023.1324189.